ISG15 Antibody [H10C1]

Katalog-Nr. F1458

Drucken

Biologische Beschreibung

Spezifität ISG15 Antibody [H10C1] detektiert endogene Spiegel des gesamten ISG15-Proteins.
Hintergrund Das Interferon-stimulierte Gen 15 (ISG15) ist ein Ubiquitin-ähnliches Protein, das eine zentrale Rolle in der angeborenen Immunität und zellulären Reaktionen auf Virusinfektionen spielt, indem es sowohl als intrazellulärer Modifikator durch ISGylierung als auch als extrazelluläres Zytokin fungiert. ISG15 besteht aus zwei Ubiquitin-ähnlichen (Ubl) Domänen, die durch ein flexibles Scharnier verbunden sind, wobei jede Domäne eine β-Grasp-Faltung bildet, ähnlich wie Ubiquitin. Schlüsselreste in der C-terminalen Domäne, wie Lys90, Trp123 und Phe149, verleihen die Spezifität für die Bindung von ISG15-aktivierenden Enzymen wie UbE1L, während die lösungsmittelzugängliche N-terminale Domäne den Transfer von ISG15 auf Zielproteine während der ISGylierung erleichtert, einem mehrstufigen Prozess, der E1 (Ube1L), E2 (UbcH8) und E3-Ligasen beinhaltet. Die ISG15-Expression wird stark durch Typ-I-Interferone (α/β) und Virusinfektionen induziert. Es kann von Immunzellen sezerniert werden, wo es Immunantworten verstärkt, indem es die Interferon-γ-Produktion stimuliert, die Proliferation natürlicher Killerzellen fördert und die Neutrophilen-Chemotaxis erhöht. Die ISGylierung modifiziert eine Vielzahl von Proteinen, einschließlich Serpin 2A, PLCγ1, ERK1/2, Jak1 und Stat1, was zu einer erhöhten Jak1- und Stat1-Aktivität und einer verstärkten Interferon-Signalisierung führt, die sich von der Ubiquitinierung unterscheidet. Die ISGylierung zielt nicht auf Proteine zum Abbau ab. Die reversible Natur der ISG15-Konjugation, reguliert durch die Protease Ubp43, gewährleistet eine dynamische Kontrolle der ISG15-Signalwege.

Nutzungsinformationen

Anwendung WB , IP Verdünnung
WB IP
1:1000 1:25
Reaktivität Human
Quelle Rabbit Monoclonal Antibody MW 15 kDa
Lagerpuffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Lagerung
(Ab dem Datum des Erhalts)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
5. Remove a small volume of lysate to determine the protein concentration;
6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
 
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 20%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.22 µm PVDF membrane is recommended )Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 60 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referenzen

  • https://pubmed.ncbi.nlm.nih.gov/15917233/
  • https://pubmed.ncbi.nlm.nih.gov/15209384/

Anwendungsdaten

WB

Validiert von Selleck

  • F1458-wb
    Lane 1: Hela, Lane 2: Hela (hIFNα1, 10 ng/ml, 16 h)